Stockscreener 앱 받기
14.36
6.45%
-0.99
시간 외 거래:
18.40
4.04
+28.13%
전일 마감가:
$15.35
열려 있는:
$15.44
하루 거래량:
339.74K
Relative Volume:
1.82
시가총액:
$524.11M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-18.55%
1개월 성능:
-0.49%
6개월 성능:
+37.15%
1년 성능:
-32.33%
1일 변동 폭
$14.21
$16.00
1주일 범위
$14.11
$17.70
52주 변동 폭
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
명칭
Rapport Therapeutics Inc
전화
857-321-8020
주소
99 HIGH STREET, BOSTON
RAPP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
14.36 | 560.24M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | H.C. Wainwright | Buy |
| 2025-04-08 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-07-02 | 개시 | Jefferies | Buy |
| 2024-07-02 | 개시 | Stifel | Buy |
| 2024-07-02 | 개시 | TD Cowen | Buy |
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsBreakout Watch & Low Drawdown Momentum Ideas - Newser
Rapport Therapeutics to report phase 2a trial results for epilepsy drug - Investing.com Canada
Will Rapport Therapeutics Inc. benefit from AI trendsJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک
Can Rapport Therapeutics Inc. continue delivering strong returnsJuly 2025 Review & Daily Stock Momentum Reports - خودرو بانک
Rapport Therapeutics to report phase 2a trial results for epilepsy drug By Investing.com - Investing.com South Africa
Rapport Therapeutics To Report Epilepsy Trial Results On MondayWill The Stock Surge Or Tumble? - Nasdaq
Rapport Therapeutics' RAP-219: A Precision Medicine Play with High Stakes in September - AInvest
Earnings visualization tools for Rapport Therapeutics Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
What hedge funds are buying Rapport Therapeutics Inc.Weekly Earnings Recap & Safe Entry Momentum Stock Tips - خودرو بانک
Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset - Seeking Alpha
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025 - The Manila Times
Rapport Therapeutics to Host Conference Call for Phase 2a Trial Topline Results of RAP-219 for Drug-Resistant Focal Onset Seizures - Quiver Quantitative
Rapport Therapeutics to Announce Topline Results for - GlobeNewswire
Key Epilepsy Drug Trial Results Coming Monday: Rapport's RAP-219 Phase 2a Data Could Impact Treatment - Stock Titan
Machine Learning Models Forecast Rapport Therapeutics Inc. UptickQuarterly Market Review & Risk Adjusted Swing Trade Ideas - beatles.ru
What is Rapport Therapeutics Inc. s 5 year growth outlookJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Building trade automation scripts for Rapport Therapeutics Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Evaluating Rapport Therapeutics Inc. with trendline analysisWeekly Profit Report & Verified Swing Trading Watchlist - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockMarket Rally & High Conviction Buy Zone Alerts - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.2025 Sector Review & Accurate Entry/Exit Alerts - Newser
Measuring Rapport Therapeutics Inc.’s beta against major indicesJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Head-To-Head Analysis: Biofrontera (NASDAQ:BFRI) and Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Will Rapport Therapeutics Inc. outperform the marketWeekly Trend Summary & High Return Trade Opportunity Guides - Newser
Real time scanner hits for Rapport Therapeutics Inc. explainedQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
What data driven models say about Rapport Therapeutics Inc.’s futureMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
Rapport Therapeutics Inc. stock prediction for this weekMarket Sentiment Summary & Safe Entry Zone Tips - Newser
Analyzing Rapport Therapeutics Inc. with multi timeframe chartsMarket Growth Review & Detailed Earnings Play Strategies - Newser
Short interest data insights for Rapport Therapeutics Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Rapport Therapeutics Inc. stock poised for growthJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
Real time breakdown of Rapport Therapeutics Inc. stock performanceMarket Trend Review & Growth Focused Stock Reports - Newser
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
What moving averages say about Rapport Therapeutics Inc.July 2025 Fed Impact & Smart Investment Allocation Tips - Newser
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Overview Report & Weekly Top Gainers Alerts - خودرو بانک
Is Rapport Therapeutics Inc. reversing from oversold territory2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Analyst Calls: Is now the right time to enter Rapport Therapeutics Inc.Earnings Trend Report & AI Powered Trade Plan Recommendations - خودرو بانک
Does Rapport Therapeutics Inc. meet Warren Buffett’s criteriaQuarterly Market Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
Fed Watch: Can Rapport Therapeutics Inc. withstand a market correction2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک
Bank Watch: How does Rapport Therapeutics Inc. compare to its peersTrade Ideas & Technical Buy Zone Confirmations - خودرو بانک
How does Rapport Therapeutics Inc. compare to its peersPortfolio Risk Summary & AI Forecast Swing Trade Picks - خودرو بانک
Rapport Therapeutics Inc (RAPP) 재무 분석
Rapport Therapeutics Inc (RAPP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):